LIC MF Healthcare Fund
Holdings
24
Concentrated
Top 10 weight
63%
Concentration
Active share
88%
Highly Differentiated
Equity
97%
Asset allocation
Portfolio
3Sectors
7Large positions
62.6%Top: Pharmaceuticals & Biotechnology
0.0%Cash
Market-cap allocation
Large cap37%
Mid cap29%
Small cap32%
Asset allocation
Equity97%
Top holdings
10.7%
Divi's Laboratories Ltd.EQUITY
9.5%6.9%
6.6%
5.6%
5.2%
Aurobindo Pharma Ltd.EQUITY
5.0%Zydus Lifesciences Ltd.EQUITY
4.9%4.7%
Fortis Healthcare Ltd.EQUITY
4.2%Gland Pharma Ltd.EQUITY
3.6%Global Health Ltd.EQUITY
3.2%TrepsDERIVATIVE
3.2%Mankind Pharma Ltd.EQUITY
3.1%IPCA Laboratories Ltd.EQUITY
3.0%2.9%
2.8%
2.8%
Biocon Ltd.EQUITY
2.8%2.7%
2.5%
2.4%
1.9%
Net Receivables / (Payables)DERIVATIVE
-0.1%AI Smart summary
Portfolio read
- 97% equity.
- 24 disclosed positions across 3 classified equity sectors.
- Largest equity sector is Pharmaceuticals & Biotechnology at 62.6% of the portfolio.
Watchpoints
- Compact 24-position portfolio; each large position can materially affect returns.
- Top 10 positions account for 63%, indicating high portfolio concentration.
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 63%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
HDFC Manufacturing fund91 holdings · 34% top 10 · 80% AS
UTI Quant Fund89 holdings · 36% top 10
Icici Prudential Energy Opportunities Fund88 holdings · 43% top 10 · 83% AS
ICICI Prudential Business Cycle Fund86 holdings · 50% top 10 · 70% AS
Edelweiss Technology Fund84 holdings · 54% top 10
Axis Business Cycles Fund81 holdings · 29% top 10 · 67% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
62.6%
29.1%
5.2%